期刊文献+

安非他酮在抑郁障碍治疗中的应用 被引量:8

下载PDF
导出
摘要 抑郁障碍是一种常见疾病,也是世界上排名第4位导致残疾的原因,以显著而持久的心境低落为主要临床特征.多数病例有反复发作倾向。据世界卫生组织(WHO)估计.至2020年,神经精神疾病将是中国第一大疾病负担。占中国疾病负担的15.5%,而抑郁症占所有神经精神疾病负担的45%。近数十年来,精神药理学的发展,为抑郁障碍的治疗开辟了一片美好的前景,
出处 《实用医学杂志》 CAS 北大核心 2010年第3期349-351,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献25

  • 1Wilkes S. Bupropion [J]. Drugs Today (Barc), 2006, 42 (10): 671-681.
  • 2Jamerson B D, Krishnan K R, Roberts J, et al. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31- item Hamilton Rating Scale for depression [J]. Psychopharmacol Bull, 2003,37 (2) : 67-78.
  • 3Thase M E, Haight B R, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials [ J ]. J Clin Psychiatry, 2005, 66 (8) : 974-981.
  • 4王雪,张波,李静,孙学礼.盐酸安非他酮缓释片治疗抑郁症的双盲双模拟随机对照试验[J].中国循证医学杂志,2007,7(6):409-414. 被引量:9
  • 5Hewett K, Chrzanowski W, Schmitz M, et al. Eight-week, placebocontrolled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR [J]. J Psychopharmacol, 2009, 23(5): 531-538.
  • 6Papakostas G I, Trivedi M H, Alpert J E, et al. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a metaanalysis of individual patient data from 10 double-blind, randomized clinical trials [J]. J Psychiatr Res, 2008, 42(2) : 134-140.
  • 7John R A, Madhukar H, Trivedi M D, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression [J]. N Engl J Med, 2006, 354(12) : 1231-1242.
  • 8Zisook S, Rush A J, Haight B R, et al. Use of bupropion in combination with serotonin reuptake inhibitors [J]. Biol Psychiatry, 2006, 59(3): 203-210.
  • 9Gabriele S, Levefich L L, Ahshuler M A, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers [J]. Am J Psychiatry, 2006, 163(2) :232- 239.
  • 10Post R M, Ahshuler L L, Leverich G S, et al. Mood switch in bipolar depression : comparison of adjunctive venlafaxine, bupropion and sertraline [J]. Br J Psychiatry, 2006, 189(2) : 124 -131.

二级参考文献19

  • 1陈晋东,国效峰,薛志敏,罗琼,李乐华,赵靖平,陈远光.盐酸安非他酮缓释片治疗抑郁症的临床试验[J].中国新药杂志,2006,15(5):379-382. 被引量:4
  • 2沈渔邨,主编.精神病学[M].3版.北京:人民卫生出版社,1994,971-977
  • 3Tomarken AJ,Dichter GS,Freid C,et al.Assessing the effects of bupropion SR on mood dimensions of depression.J Affect Disord,2004,78(3):235-241.
  • 4Glod CA,Lynch A,Flynn E,et al.Open trial of bupropion SR in adolescent major depression.J Child Adolesc Psychiatr Nurs,2003,16(3):123-130.
  • 5Jamerson BD,Krishnan KR,Roberts J,et al.Effect of bupropion SR on specificsymptom clusters of depression:analysis of the 31-item Hamilton Rating Scale for depression.Psychopharmacol Bull,2003,37(2):67-78.
  • 6Croft H,Houser TL,Jamerson BD,et al.Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks.Clin Ther,2002,24(4):662-672.
  • 7Weihs KL,Houser TL,Batey S R,et al.Continuation phase treatment withbupropion SR effectively decreases the risk for relapse of depression.Biol Psychiatry,2002,51(9):753-761.
  • 8Nieuwstraten CE,DolovichLR.Bupropion versus selective serotoninreuptake inhibitors for treatment of depression.Ann Pharmacother,2001,35(12):1608-1613.
  • 9Steffens DC,Doraiswamy PM,McQuoid DR.Bupropion SR in the naturalistictreatment of elderly patients with major depression.Int J Geriatr Psychiatry,2001,16(9):862-865.
  • 10Weihs KL,Sette EC Jr,Batey SR,et al.Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.J Clin Psychiatry,2000,61(3):196-202.

共引文献8

同被引文献72

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部